FDA Issues Guidance for Industry on Generic Drug User Fee Amendments of 2012: Q&A August 29, 2012
Michael A. Swit, Esq. Special Counsel, FDA Law Practice Duane Morris LLP San Diego maswit@duanemorris.com 619-744-2215 (direct) 760-815-4762 (cell)
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
raps@raps.org+1 301 770 2920
JoinMy RAPS DashboardLearn More
About UsTerms of UsePrivacy Policy